Lipoprotein(a) levels and time to cardiovascular benefit with alirocumab in patients with recent acute coronary syndrome

Author(s):: Ray, K.K.; Szarek, M.; Bhatt, D.L.; Bittner, V.A.; Fazio, S.; Goodman, S.G.; Harrington, R.A.; Jukema, W.; White, H.D.; Steg, G.; Schwartz, G.G.

Published: 2025
Publication type: Article / Letter to editor

acute coronary syndromesalirocumabMACEMALE

Date issued: 2025-11-17
Language: English
Publisher: ELSEVIER SCIENCE INC
Is part of: Journal of the American College of Cardiology (2025), Vol. 86, no. 21, p. 2071-2076
hdl: 1887/4300324
doi: 10.1016/j.jacc.2025.08.043